Delta, Kelowna, BC - June 18, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Investor Ideas Potcasts, Cannabis News and Stocks on the Move June 18th (TSXV: $OGI.V) (NASDAQ: $OGI) (TSXV: $META.V)( CSE: $CRFT.C) (CSE: $TIM-U.C)
Today's podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com "potcasts", looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.
Today we are looking at a few early announcements.
But first, The Global Cannabis Partnership (GCP), a collaboration of leaders in the government-sanctioned cannabis industry, released today a corporate social responsibility framework that its 45-member organizations have agreed to adhere to, establishing a standard for the new and rapidly growing cannabis industry worldwide.
"We're building an industry for the future," said the GCP's Executive Director Kim Wilson. "It's one thing to have a legal license to operate; earning and keeping a social license is another story. We have a long road ahead of us, but today's announcement is an important step in the right direction."
The world's first Responsible Cannabis Framework (RCF) seeks to positively influence the industry's impacts on the environment and society, and aims to support GCP members in continually improving their corporate performance over time.
Using best practices from within and outside the industry, the RCF goes beyond minimum compliance with all relevant and applicable laws, articulating expectations of members for evaluating, developing, implementing, measuring and disclosing their environmental, social and governance initiatives.
"The RCF was developed through extensive research and consultation with a variety of stakeholders," said Rick Petersen, one of the world's experts in corporate responsibility and author of the Framework. "We knew that we could rely on the experience of other industries, while at the same time coming up with the right steps to meet the challenges in our specific sector."
Members have all agreed to the Framework's four guiding principles - responsibility, collaboration, transparency and continuous improvement - and have up to a year to complete work necessary to apply for one of four certification categories. Minimum requirements include, among others, minimizing greenhouse gas emissions; promoting responsible use, and reinforcing ethical conduct. The formal certification process was developed by EY and member applications will be submitted to an independent evaluation panel.
The GCP expects members to make improvements when Framework standards are not met and to develop mechanisms to ensure ongoing compliance and continuous improvement.
Organigram Holdings Inc. (TSXV: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading licensed producer of cannabis, announced that it has signed an exclusive agreement with Feather Company Ltd., a cannabis innovator and lifestyle brand committed to the production of premium-quality products that enhance the cannabis experience for customers. The disposable vaporizer pen and 5/10 thread cartridges for targeted adult-use customer segments will be available following legalization of this product category currently scheduled to come into effect as of October 2019.
Organigram, through the Edison Cannabis Co. brand, has an exclusive license to Feather's proprietary vaporizer pen technology and form factor. The relationship will also allow Organigram to represent Feather across Canada from a commercial perspective. This agreement reflects both companies' commitment to transformative thinking and unique customer experiences.
"A successful recreational cannabis market requires that licensed producers and their partners continually reimagine the cannabis experience," says Ray Gracewood, Senior Vice President, Marketing and Communications, Organigram. "It is critical for Organigram to find unique ways to offer customers the kind of value that will help differentiate our brands. The future is in providing unique opportunities for customers to explore the product."
Feather's technology and hardware offers Organigram's Edison brand a unique, proprietary delivery mechanism for discerning and sophisticated consumers and will compliment the companies recently announced partnership with PAX, a leader in closed-loop vaporizable technology offered through the PAX Era product line.
National Access Cannabis Corp. (TSXV: META), Canada's largest cannabis retailer according to provincial licensing statistics, today announced it has received three additional licences from the Alberta Gaming, Liquor and Cannabis Commission to open cannabis retail stores in Alberta. The retail stores will be located in the cities of Calgary, Edmonton and Airdrie. The announcement comes following the previously released news that the AGLC has lifted the moratorium on new cannabis retail licences.
"We're growing rapidly in Alberta," said Mark Goliger, CEO of NAC. "With three new licences and the new location recently opened June 5th in the Varsity neighbourhood in Calgary, we continue to expand our private cannabis retailing footprint in Alberta and our growth isn't done. We have 15 additional licences submitted and 7 more stores built awaiting licensing and regulatory approval in Alberta."
NAC is the national leader in retail cannabis. Currently operating in three provinces, NAC has applied for licences in British Columbia and plans to make applications for licences in Ontario once licensing opens up to more private retailers. NAC's experienced team of retail industry professionals is focused on achieving its business plan of having 40 operating stores by the end of calendar 2019, and 110 operating stores by the end of calendar 2020.
Pasha Brands Ltd. (CSE: CRFT) (OTC:CRFTF) introduced BC Craft Supply Co. Ltd. as the first in its line of nearly a dozen leading craft cannabis brands that aim to rectify Canada's ongoing product shortage and quality issues. Through its subsidiaries, Pasha is Canada's first licensed producer exclusively focused on assisting the original cannabis industry in Canada in gaining access to the regulated market through Health Canada's new micro cultivation licensing regime.
BC Craft is helping Canada's leading cannabis growers acquire micro-cultivation licences by providing comprehensive support and advice, as well as all necessary testing, processing and packaging to help growers legally bring their products to market. With Pasha's recent acquisition of Medcann Health Products Ltd., a fully licensed, Health Canada approved facility, BC Craft is uniquely positioned to work with the thousands of craft producers in Canada that are now looking to transition into Canada's new regulated supply chain.
"I'm confident that what BC Craft Supply Co. will be able to contribute to the legal market will set the standard for craft production and supply chain management, not just in Canada but internationally," said Jason Longden, CEO of Pasha Brands. "Confidence in the brand has already inspired craft cultivators throughout British Columbia and from across the country to join our team, and we're eager to help solve Canada's ongoing supply issue with quality cannabis the legal market has yet to see."
Representing the first wave of Pasha's industry-shaking craft cannabis brands, BC Craft is a service provider in contract with some of Canada's best farmers to ensure their timely participation and competitive edge in Canada's burgeoning legal cannabis market. Spurred by a passion to support small businesses and pay respect to the cultivators that have always been the country's top choice for quality cannabis, the brand is working to assist in their transition into the market so that consumers can have legal access to legitimate and sought-after 'BC Bud' at long last.
With Medcann now part of the Pasha group, BC Craft will coordinate the purchase of craft cannabis from licensed micro cultivators under a supply agreement, kicking off the transition from the unregulated market-where nearly 85 percent of all cannabis sales in Canada still take place-to the legal one. Once micro cultivators are licensed and operational, BC Craft anticipates an annual supply of approximately 50,000 kilograms of cannabis per 100 micro cultivators in its supply chain. Industry estimates place the number of grey market producers in BC alone at as many as 20,000.
Jose Hidalgo, Founder and CEO of Cansortium Inc. (CSE: TIUM-U), a vertically-integrated, global provider of premium-quality medical cannabis operating under the Fluent brand, issued the following statement in response to Texas Governor Greg Abbott's signing of HB 3703 which expands access to low-level THC (less than 0.5%) cannabis products to benefit Texas residents coping with certain chronic medical conditions.
"The Cansortium team is excited to work with the State of Texas to provide cultivation, processing and home delivery operations in Texas in order to bring the benefits of our premium-grade, low-level THC, cannabis products to Texas residents who are coping with chronic medical conditions. As one of the three medical cannabis licensees in the state of Texas, our company is also well-positioned to begin building a network of conveniently located dispensaries in key markets where authorized under the new law by the Texas Department of Public Safety."
The new law, which is now effective, contains the following three key provisions that, together, are expected to increase legal access to low-level THC medical cannabis products:
- Expands the range of medical conditions for which licensed specialty physicians may recommend low-level THC cannabis products (containing up to 0.5 percent THC). In addition to intractable epilepsy, which was previously the sole eligible condition, the following additional chronic conditions now qualify for cannabis recommendation:
- All forms of epilepsy
- Terminal Cancer
- Amyotrophic Lateral Sclerosis (ALS)
- Incurable neurological disease
- Parkinson's Disease
- Multiple Sclerosis
- Seizure disorders
- Enables a patient to gain access to medical cannabis products based on the recommendation of a single licensed specialty physician, versus the previous requirement that a patient obtain recommendations from at least two licensed physicians.
- Authorizes the Texas Department of Public Safety to oversee approval, regulation and administration of cannabis dispensaries to be constructed and operated by the state's three medical cannabis licensees, which include Cansortium.
Cansortium currently provides home-delivery services across Texas from a 4,000 square-foot cultivation facility and adjacent 650 square-foot processing facility in Schulenburg, Texas, with the ability to expand the cultivation facility up to an additional 200,000 square-feet to meet incremental demand.
Subscribe to the new cannabis podcast series:
To hear more Investorideas.com. podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Social Media